Phenobarbital, hyoscyamine, atropine, and scopolamine and Ranolazine interaction

Phenobarbital, hyoscyamine, atropine, and scopolamine and Ranolazine: the Ranolazine prescribing label flags this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Ranolazine (ASPRUZYO SPRINKLE) label · effective 2025-01-29

Major

CYP3A inducers (e.g., rifampin, phenobarbital, St.

Contraindicationsnames Phenobarbital, hyoscyamine, atropine, and scopolamineView label on DailyMed
Minor

CYP3A Inducers Concomitant use of ASPRUZYO Sprinkle with CYP3A inducers such as rifampin, rifabutin, rifapentine, phenobarbital, phenytoin, carbamazepine, and St.

Drug interactionsnames Phenobarbital, hyoscyamine, atropine, and scopolamineView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.